| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.80B | +14.2% |
| Cost of Revenue | $1.33B | +14.8% |
| Gross Profit | $5.47B | +14.0% |
| R&D Expense | $815.5M | +13.8% |
| SG&A Expense | $233.4M | -1.9% |
| Operating Income | $2.08B | +15.6% |
| Interest Expense | $20.1M | +0.5% |
| Pre-tax Income | $2.28B | +10.9% |
| Income Tax | $439.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.50B | -13.2% |
| Accounts Receivable | $1.69B | +15.6% |
| Inventory | $399.5M | +26.6% |
| Current Assets | $5.90B | -1.2% |
| Total Assets | $10.39B | +6.4% |
| Current Liabilities | $5.03B | +24.0% |
| Long-term Debt | $496.6M | -50.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.59B | +14.7% |
| Investing Cash Flow | -$599.1M | +17.6% |
| Financing Cash Flow | -$2.37B | -4633.5% |
| +54.7% |
| Net Income | $1.85B | +6.2% |
| EPS (Basic) | $2.45 | +7.5% |
| EPS (Diluted) | $2.42 | +7.1% |
| Total Liabilities |
| $9.15B |
| +10.7% |
| Stockholders' Equity | $1.24B | -17.2% |